期刊文献+

碱剩余早期动态变化与严重脓毒症和脓毒症休克患者预后的关系 被引量:3

Relationships between early change of base excess and the prognosis of patients with severe sepsis and septic shock
下载PDF
导出
摘要 目的探讨碱剩余早期动态变化对严重脓毒症和脓毒症休克患者预后的早期评估作用。方法采用回顾性分析方法,记录严重脓毒症和脓毒症休克患者入院后碱剩余及急性生理和慢性健康状况评分Ⅲ(APACHEⅢ),分析碱剩余与APACHEⅢ评分及脓毒症预后的关系,并比较不同碱剩余组预后的情况。结果死亡组和存活组碱剩余值及早期变化趋势明显不同(P〈0.05,P〈0.01),不同碱剩余组间预后比较差异有统计学意义(P〈0.05,P〈0.01),碱剩余与APACHEⅢ评分间有较好的一致性。早期碱剩余越高,预后越好,治疗后碱剩余恢复较快组预后良好。结论碱剩余是评估严重脓毒症和脓毒症休克严重性及预后较好的指标,其应用价值可与APACHEⅢ评分媲美,而且两者联合预测效果更好。 Objective To explore the clinical value of early changes of base excess in the prognostic evaluation of patients with severe sepsis and septic shock. Methods To retrospectively analyze and record the base excess and acute physiology and chronic health evaluation(APACHE) Ⅲ of the severe sepsis and septic shock patients after admission to hospital. To study the relationship of base excess with APACHE Ⅲ and the prognosis. The prognosis of different base excess groups were compared. Results The base excess and early changes between survival groups and nonsurvival groups were different,and there was statistical significance ( P 〈 0. 05, P 〈 0.01 ). The prognosis of different base excess groups had statistical significance( P 〈0. 05, P 〈0.01 ). Base excess and APACHE Ⅲ had a better consistency. The prognosis was better in higher base excess group, and the patients with quicker recovery after treatment had better prognosis. Conclusion Base excess is a better marker to assess the severity and prognosis in severe sepsis and septic shock patients, its value could be comparable to the APACHE Ⅲ score, predictive results could be better by taking joint action.
出处 《中国急救医学》 CAS CSCD 北大核心 2009年第2期100-102,共3页 Chinese Journal of Critical Care Medicine
关键词 碱剩余 急性生理和慢性健康状况评分Ⅲ 脓毒症 预后 Base excess APACHEⅢ Sepsis Prognosis
  • 相关文献

参考文献7

  • 1Delliuger RP, Cadet JM, Masur H ,et al. Surviving Sepsis Campaign Management Guidelines Committee ( 2004 ) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J]. Crit Care Meal,2004,32(3) :858 -873.
  • 2Spahnl DR, Cerny V, Coats TJ, et al. Management of bleeding following major trauma: a European guideline [ J ]. Crit Care, 2007,11 (1) :414 -436.
  • 3Raghavan M, Marik PE. Management of sepsis during the early "golden hour" [J]. J Emerg Med,2006,31 (2) :185 - 199.
  • 4Rixen D, Siegel JH. Bench - to - bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock[J]. Crit Care,2005,9(5) :441 -453.
  • 5Park M, Azevedo LCP, Maciel AT,et al. Evolutive standard base excess and serumlactate level in severe sepsis and septic shock patients resuscitated with early goal - directed therapy: still outcome markers [J]. Clinics,2006,61 (1) :47 -52.
  • 6Palma LC, Ferreira GF, Amaral ACKB, et al. Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation [J]. Crit Care,2003,7(4) :39.
  • 7黄顺伟,管向东,陈娟,欧阳彬,陈敏英.四种评分系统对重症脓毒症病人动态评分的比较[J].中国急救医学,2005,25(11):802-803. 被引量:10

二级参考文献9

  • 1Knaus WA, Draper EA, Wagner DP, et al. APACHE Ⅱ: a severity of disease classification system[J] .Crit Care Med, 1985,13:818- 829.
  • 2Knaus WA, Wagner DP, Draper EA, et al. The APACHE Ⅲ prognostic system risk prediction of hospital mortality for critically ill hospitalized adults[J]. Chest, 1991,100:1619 - 1636.
  • 3Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score( SAP Ⅱ )based on a European/North American multicenter study [ J ]. JAMA, 1993,270:2957 - 2963.
  • 4Marshall JC, Cook DJ, Christon N, et al. Multiple organ dysfnnction score: are reliable descriptor of a comp lex clinical outcome[J]. Crit Care Med, 1995,23,1638 - 1652.
  • 5Markgraf R, Deutschinoff G, Pientka L, et al. Comparison of acute physiology and chronic health evaluation Ⅱ and Ⅲ and simplified acute physiology score Ⅱ: a prospective cohort study evaluating these methods to predict outcome in a German interdisplinary intensive care uint[J].Crit Care Med,2000,28(1) :26 - 33.
  • 6Bone RC, Balk RA, Gerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis [ J ].American Colleges of Chest Physician/Society of Critical Care Medicine Consensus Conference. Chest, 1992,101:1644 - 1655.
  • 7Jacobs S, Zulekia M, Mphansa T.The multiple organ dysfunction score as a descriptor of patient outcome in septic shock compared with two other scoring systems [ J ]. Crit Care Med, 1999,27: 741 - 743.
  • 8Buckley TA, Gomersall CD, Ramsay SJ. Validation of the multiple organ dysfunction (MOD) score in critically ill medical and surgical patients [J]. Intensive Care Med,2003,29(12) :2216 - 2222.
  • 9Taylor SL, Morgan DL, Denson KD, et al. Comparison of the Ranson,Glasgow, and APACHE Ⅱ scoring systems to a multiple organ system score in predicting patient outcome in pancreatitis[J]. Am J Surg,2005,189(2) :219- 222.

共引文献9

同被引文献32

  • 1Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis[J]. Intensive Care Med, 2010, 36(2): 222-231.
  • 2American College of Chest Physiciana/Society of Critical Care Medicine Consensus Confeernce. Definitionsforse psisa ndorgan failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992, 20(6): 864-874.
  • 3Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med, 2008, 36(1): 296-327.
  • 4Lee SW, Hong YS, Park DW, et al. Lactic acidosis not hyperlactatemia as a predictor of inhospital mortality in septic emergency patients[J]. Emerg Med J, 2008, 25(10): 659-665.
  • 5Gunnerson KJ, Saul M, He S, et al. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients[J]. Crit Care, 2006, 10(1): R22.
  • 6Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: arandomized clinical trial[J]. JAMA, 2010, 303(8): 739-746.
  • 7Palma LC, Ferreira GF, Amaral ACKB, et al. Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation [J]. Critical Care, 2003, 7(Suppl 3): 39.
  • 8Allen M. Lactate and acid base as a hemodynamic monitor and markers of cellular perfusion[J]. Pediatr Crit Care Med, 2011, 12(4 Suppl): S43- S49.
  • 9Surbatovic M, Radakovic S, Jevtic M, et al. Predictive value of serum bicarbonate, arterial base deficit/excess and SAPS Ⅲ score in critically ill patients[J]. Gen Physiol Biophys, 2009, 28: 271-276.
  • 10Noritomi DT, Soriano FG, Kellum JA, et al. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study[J]. Crit Care Med, 2009, 37(10): 2733-2739.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部